Skip to content
PubMed This is a summary of 91 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 91 referenced papers

Top Authors

Sagar U. Nigwekar
Massachusetts General Hospital
Daniela Kroshinsky
Massachusetts General Hospital
Rosalynn M. Nazarian
Massachusetts General Hospital
Rajeev Kumar Malhotra
Harvard University
Jeremy Goverman
Massachusetts General Hospital
Rokea A. el‐Azhary
Mayo Clinic in Arizona
Smeeta Sinha
Manchester Academic Health Science Centre
Jürgen Floege
Universitätsklinikum Aachen
Ravi Thadhani
Massachusetts General Hospital
Rafael Kramann
Erasmus MC

Top Institutions

Ranked by publications Top 10 institutions
05

Manchester Academic Health Science Centre

Manchester, United Kingdom

14 papers
Contributors Smeeta Sinha
09

Zhongda Hospital Southeast University

Nanjing, China

7 papers
10

Erasmus MC

Rotterdam, The Netherlands

5 papers
Contributors Rafael Kramann

References

References (91)
  1. 1

    Calciphylaxis: from the disease to the diseased.

    Oliveira TM, Frazão JM

    Journal of nephrology 2015; (28(5)):531-40 doi:10.1007/s40620-015-0192-2.

    PMID: 25835730
  2. 2

    The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial.

    Floege J, Kubo Y, Floege A, et al.

    Clinical journal of the American Society of Nephrology : CJASN 2015; (10(5)):800-7 doi:10.2215/CJN.10221014.

    PMID: 25887067
  3. 3

    Calciphylaxis: risk factors, diagnosis, and treatment.

    Nigwekar SU, Kroshinsky D, Nazarian RM, et al.

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2015; (66(1)):133-46.

    PMID: 25960299
  4. 4

    Penile lesion in end-stage renal failure - cancer or otherwise?: Calcific uremic arteriolopathy presenting with a penile lesion.

    Malthouse T, Lam W, Brewin J, et al.

    Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2015; (9(3-4)):136-7 doi:10.5489/cuaj.2331.

    PMID: 26085872
  5. 5

    Raman spectroscopy for label-free identification of calciphylaxis.

    Lloyd WR, Agarwal S, Nigwekar SU, et al.

    Journal of biomedical optics 2015; (20(8)):80501 doi:10.1117/1.JBO.20.8.080501.

    PMID: 26263412
  6. 6

    Multidisciplinary approach to calcific uremic arteriolopathy.

    Nigwekar SU

    Current opinion in nephrology and hypertension 2015; (24(6)):531-7 doi:10.1097/MNH.0000000000000175.

    PMID: 26371529
  7. 7

    Sodium thiosulfate is effective in calcific uremic arteriolopathy complicating chronic hemodialysis.

    Malbos S, Ureña-Torres P, Bardin T, Ea HK

    Joint bone spine 2016; (83(1)):89-92.

    PMID: 26494591
  8. 8

    Calciphylaxis: a case series and the role of radiology in diagnosis.

    Bonchak JG, Park KK, Vethanayagamony T, et al.

    International journal of dermatology 2016; (55(5)):e275-9 doi:10.1111/ijd.13043.

    PMID: 26518613
  9. 9

    Gastrointestinal Bleeding Secondary to Calciphylaxis.

    Gupta N, Haq KF, Mahajan S, et al.

    The American journal of case reports 2015; (16()):818-22 doi:10.12659/ajcr.895164.

    PMID: 26572938
  10. 10

    Warfarin and Vascular Calcification.

    Poterucha TJ, Goldhaber SZ

    The American journal of medicine 2016; (129(6)):635.e1-4.

    PMID: 26714212
  11. 11

    Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.

    Brandenburg VM, Kramann R, Rothe H, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2017; (32(1)):126-132 doi:10.1093/ndt/gfv438.

    PMID: 26908770
  12. 12

    Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis?

    Brandenburg VM, Evenepoel P, Floege J, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2016; (31(8)):1211-9 doi:10.1093/ndt/gfw025.

    PMID: 27005994
  13. 13

    Calciphylaxis of the Breast: A Case Report and Literature Review.

    Hall DJ, Gentile LF, Duckworth LV, et al.

    The breast journal 2016; (22(5)):568-72 doi:10.1111/tbj.12632.

    PMID: 27332900
  14. 14

    Calciphylaxis in peritoneal dialysis patients: a single center cohort study.

    Zhang Y, Corapi KM, Luongo M, et al.

    International journal of nephrology and renovascular disease 2016; (9()):235-241 doi:10.2147/IJNRD.S115701.

    PMID: 27698566
  15. 15

    Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis.

    McCarthy JT, El-Azhary RA, Patzelt MT, et al.

    Mayo Clinic proceedings 2016; (91(10)):1384-1394 doi:10.1016/j.mayocp.2016.06.025.

    PMID: 27712637
  16. 16

    Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis.

    Nigwekar SU, Bloch DB, Nazarian RM, et al.

    Journal of the American Society of Nephrology : JASN 2017; (28(6)):1717-1722 doi:10.1681/ASN.2016060651.

    PMID: 28049648
  17. 17

    Warfarin-Associated Nonuremic Calciphylaxis.

    Yu WY, Bhutani T, Kornik R, et al.

    JAMA dermatology 2017; (153(3)):309-314 doi:10.1001/jamadermatol.2016.4821.

    PMID: 28099971
  18. 18

    Calciphylaxis.

    Nigwekar SU

    Current opinion in nephrology and hypertension 2017; (26(4)):276-281 doi:10.1097/MNH.0000000000000328.

    PMID: 28375870
  19. 19

    Early clinical presentations and progression of calciphylaxis.

    Ghosh T, Winchester DS, Davis MDP, et al.

    International journal of dermatology 2017; (56(8)):856-861 doi:10.1111/ijd.13622.

    PMID: 28436018
  20. 20

    The Role of Bone Scintigraphy with Single-photon Emission Computed Tomography-computed Tomography in the Diagnosis and Evaluation of Calciphylaxis.

    Martineau P, Pelletier-Galarneau M, Bazarjani S

    World journal of nuclear medicine 2017; (16(2)):172-174 doi:10.4103/1450-1147.203076.

    PMID: 28553189
  21. 21

    Underreported use of palliative care and patient-reported outcome measures to address reduced quality of life in patients with calciphylaxis: a systematic review.

    Riemer CA, El-Azhary RA, Wu KL, et al.

    The British journal of dermatology 2017; (177(6)):1510-1518 doi:10.1111/bjd.15702.

    PMID: 28580642
  22. 22

    Systematic review of sodium thiosulfate in treating calciphylaxis in chronic kidney disease patients.

    Peng T, Zhuo L, Wang Y, et al.

    Nephrology (Carlton, Vic.) 2018; (23(7)):669-675 doi:10.1111/nep.13081.

    PMID: 28603903
  23. 23

    Management of a Complex Peristomal Calciphylaxis: A Case Study.

    Famorca M, Beauchaine D, Angulo N

    Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society 2017; (44(4)):380-383 doi:10.1097/WON.0000000000000343.

    PMID: 28682855
  24. 24

    Extraosseous Calcification of the Esophagus: Clinicopathologic Correlates of Esophageal Mucosal Calcinosis.

    Garber A, Arora Z, Welch N, et al.

    ACG case reports journal 2017; (4()):e108 doi:10.14309/crj.2017.108.

    PMID: 28932755
  25. 25

    Histopathology of Calciphylaxis: Cohort Study With Clinical Correlations.

    Chen TY, Lehman JS, Gibson LE, et al.

    The American Journal of dermatopathology 2017; (39(11)):795-802 doi:10.1097/DAD.0000000000000824.

    PMID: 29053546
  26. 26

    Calciphylaxis after parathyroidectomy.

    Karmegam S, Shetty A

    Hemodialysis international. International Symposium on Home Hemodialysis 2017; (21 Suppl 2()):S62-S66 doi:10.1111/hdi.12599.

    PMID: 29064176
  27. 27

    [Calcific uremic arteriolopathy (calciphylaxis)  : update in 2018].

    Alves C, Ernandez T, Stoermann Chopard C

    Revue medicale suisse 2018; (14(595)):426-429.

    PMID: 29465875
  28. 28

    Calciphylaxis in end-stage liver and renal disease patients before and after transplant.

    Couri T, Stier M, Mikolajczyk A, Aronsohn A

    Clinical transplantation 2018; (32(6)):e13272 doi:10.1111/ctr.13272.

    PMID: 29714030
  29. 29

    An Update on Calciphylaxis.

    García-Lozano JA, Ocampo-Candiani J, Martínez-Cabriales SA, Garza-Rodríguez V

    American journal of clinical dermatology 2018; (19(4)):599-608 doi:10.1007/s40257-018-0361-x.

    PMID: 29808451
  30. 30

    A case report of pediatric calciphylaxis-a rare and potentially fatal under diagnosed condition.

    Stârcea M, Gavrilovici C, Elsayed A, et al.

    Medicine 2018; (97(27)):e11300 doi:10.1097/MD.0000000000011300.

    PMID: 29979398
  31. 31

    The Role of Matrix Gla Protein (MGP) in Vascular Calcification.

    Bjørklund G, Svanberg E, Dadar M, et al.

    Current medicinal chemistry 2020; (27(10)):1647-1660 doi:10.2174/0929867325666180716104159.

    PMID: 30009696
  32. 32

    Metabolic acidosis after sodium thiosulfate infusion and the role of hydrogen sulfide.

    Hunt GM, Ryder HF

    Clinical case reports 2018; (6(8)):1595-1599 doi:10.1002/ccr3.1673.

    PMID: 30147912
  33. 33

    Factors associated with false-negative pathologic diagnosis of calciphylaxis.

    Williams EA, Moy AP, Cipriani NA, et al.

    Journal of cutaneous pathology 2019; (46(1)):16-25 doi:10.1111/cup.13364.

    PMID: 30280393
  34. 34

    Management of Penile Calciphylaxis: A Case Study.

    Zillioux JM, Geisenhoff A, Gray M

    Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society 2018; (45(6)):536-539 doi:10.1097/WON.0000000000000483.

    PMID: 30395130
  35. 35

    Calciphylaxis in patients with chronic kidney disease: A disease which is still bewildering and potentially fatal.

    Cucchiari D, Torregrosa JV

    Nefrologia 2018; (38(6)):579-586 doi:10.1016/j.nefro.2018.05.007.

    PMID: 30415999
  36. 36

    A Rare Case of Multiorgan Calciphylaxis in a Patient with Stage 5 Chronic Kidney Disease.

    Ahmad A, Albaghli A, Michael A, et al.

    Case reports in urology 2018; (2018()):9603680 doi:10.1155/2018/9603680.

    PMID: 30420934
  37. 37

    Calciphylaxis-as a drug induced adverse event.

    Portales-Castillo I, Kroshinsky D, Malhotra CK, et al.

    Expert opinion on drug safety 2019; (18(1)):29-35 doi:10.1080/14740338.2019.1559813.

    PMID: 30574812
  38. 38

    The use of cinacalcet for the treatment of calciphylaxis in patients with chronic kidney disease: A comprehensive review.

    Deen J, Schaider H

    The Australasian journal of dermatology 2019; (60(3)):e186-e194 doi:10.1111/ajd.12992.

    PMID: 30666627
  39. 39

    Revisiting therapeutic options for calciphylaxis.

    Seethapathy H, Nigwekar SU

    Current opinion in nephrology and hypertension 2019; (28(5)):448-454 doi:10.1097/MNH.0000000000000520.

    PMID: 31169527
  40. 40

    Clinicopathologic Features and Calcium Deposition Patterns in Calciphylaxis: Comparison With Gangrene, Peripheral Artery Disease, Chronic Stasis, and Thrombotic Vasculopathy.

    McMullen ER, Harms PW, Lowe L, et al.

    The American journal of surgical pathology 2019; (43(9)):1273-1281 doi:10.1097/PAS.0000000000001302.

    PMID: 31192861
  41. 41

    Correlation between clinical and pathological features of cutaneous calciphylaxis.

    Dutta P, Chaudet KM, Nazarian RM, et al.

    PloS one 2019; (14(6)):e0218155 doi:10.1371/journal.pone.0218155.

    PMID: 31194797
  42. 42

    Calciphylaxis After Kidney Transplant.

    Ryan MP, Ross LS

    Cureus 2019; (11(5)):e4695 doi:10.7759/cureus.4695.

    PMID: 31338270
  43. 43

    [The nightmare of calciphylaxis].

    Ulrich M, Götz M, Krah X

    Aktuelle Urologie 2021; (52(1)):70-72 doi:10.1055/a-0892-1899.

    PMID: 31344746
  44. 44

    Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study.

    Gaisne R, Péré M, Menoyo V, et al.

    BMC nephrology 2020; (21(1)):63 doi:10.1186/s12882-020-01722-y.

    PMID: 32101140
  45. 45

    Hyperbaric oxygen therapy in patients suffering from wounds in calciphylaxis: a narrative review.

    Charaghvandi DA, Teguh DN, van Hulst RA

    Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2020; (47(1)):111-123 doi:10.22462/01.03.2020.12.

    PMID: 32176952
  46. 46

    Vascular Calcification in Chronic Kidney Disease: The Role of Vitamin K- Dependent Matrix Gla Protein.

    Roumeliotis S, Dounousi E, Salmas M, et al.

    Frontiers in medicine 2020; (7()):154 doi:10.3389/fmed.2020.00154.

    PMID: 32391368
  47. 47

    Diagnosing Calciphylaxis: A Review With Emphasis on Histopathology.

    Bahrani E, Perkins IU, North JP

    The American Journal of dermatopathology 2020; (42(7)):471-480 doi:10.1097/DAD.0000000000001526.

    PMID: 32604207
  48. 48

    Isolated Mesenteric Calciphylaxis With Ischemic Colitis in a Hemodialysis Patient Without Active Cutaneous Calciphylaxis: A Case Report of Calcific Uremic Arteriolopathy.

    Tan RYP, Juneja R, Gunawardane DN, Milton CA

    Kidney medicine 2020; (2(2)):209-212 doi:10.1016/j.xkme.2019.12.005.

    PMID: 32734240
  49. 49

    Calciphylaxis - Case Report.

    Prohic N, Masnic F, Fazlic MK, et al.

    Medical archives (Sarajevo, Bosnia and Herzegovina) 2020; (74(3)):233-235 doi:10.5455/medarh.2020.74.233-235.

    PMID: 32801442
  50. 50

    Management of Cutaneous Calciphylaxis.

    Kodumudi V, Jeha GM, Mydlo N, Kaye AD

    Advances in therapy 2020; (37(12)):4797-4807 doi:10.1007/s12325-020-01504-w.

    PMID: 32997277
  51. 51

    Risk factors for calciphylaxis in Chinese hemodialysis patients: a matched case-control study.

    Liu Y, Zhang X, Xie X, et al.

    Renal failure 2021; (43(1)):406-416 doi:10.1080/0886022X.2021.1884094.

    PMID: 33641601
  52. 52

    Clinical mimickers of calciphylaxis: A retrospective study.

    Gabel CK, Blum AE, François J, et al.

    Journal of the American Academy of Dermatology 2021; (85(6)):1520-1527 doi:10.1016/j.jaad.2021.03.035.

    PMID: 33744358
  53. 53

    The Multifactorial Pathogenesis of Calciphylaxis: A Case Report.

    Turek M, Stępniewska J, Różański J

    The American journal of case reports 2021; (22()):e930026 doi:10.12659/AJCR.930026.

    PMID: 34097671
  54. 54

    Successful Treatment of Calciphylaxis in a Young Female With End-Stage Renal Disease on Peritoneal Dialysis With Parathyroidectomy, Intensification of Dialysis, and Sodium Thiosulphate-A Case Report and Literature Review.

    Roy S, Reddy SN, Garcha AS, et al.

    Journal of investigative medicine high impact case reports 2021; (9()):23247096211060580 doi:10.1177/23247096211060580.

    PMID: 34845938
  55. 55

    Manifestation of Nonuremic Calciphylaxis in the Extremities: Case Report and Review.

    Zulauf EE, Connors JC, Hardy MA

    The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons 2022; (61(5)):e41-e47 doi:10.1053/j.jfas.2021.10.024.

    PMID: 34876341
  56. 56

    Prevalence and Clinical Characteristics of Calciphylaxis in Chinese Hemodialysis Patients.

    Liu Y, Yang C, Yang X, et al.

    Frontiers in medicine 2022; (9()):902171 doi:10.3389/fmed.2022.902171.

    PMID: 35755071
  57. 57

    Calciphylaxis and Kidney Disease: A Review.

    Gallo Marin B, Aghagoli G, Hu SL, et al.

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2023; (81(2)):232-239 doi:10.1053/j.ajkd.2022.06.011.

    PMID: 35970430
  58. 58

    Perioperative Management of Calciphylaxis: Literature Review and Treatment Recommendations.

    Strand N, Maloney J, Wu S, et al.

    Orthopedic reviews 2022; (14(3)):37573 doi:10.52965/001c.37573.

    PMID: 36034726
  59. 59

    Characterization of Risk Factors for Calciphylaxis in Hemodialysis Patients in the Fraser Health Renal Program - A Matched Case-Control Retrospective Review.

    Jang A, Mark Ho MH, Yan L

    Journal of pharmacy practice 2023; (36(6)):1424-1437 doi:10.1177/08971900221118444.

    PMID: 36036088
  60. 60

    Patient-Reported and Clinical Outcomes Among Patients With Calciphylaxis.

    Wen W, Krinsky S, Kroshinsky D, et al.

    Mayo Clinic proceedings. Innovations, quality & outcomes 2023; (7(1)):81-92 doi:10.1016/j.mayocpiqo.2022.12.006.

    PMID: 36712824
  61. 61

    Clinical features and outcomes of calciphylaxis in Chinese patients with chronic kidney disease.

    Jiao Y, Sun L, Xie X, et al.

    Nephrology (Carlton, Vic.) 2023; (28(6)):305-314 doi:10.1111/nep.14156.

    PMID: 36883928
  62. 62

    Intravenous Sodium Thiosulphate for Calciphylaxis of Chronic Kidney Disease: A Systematic Review and Meta-analysis.

    Wen W, Portales-Castillo I, Seethapathy R, et al.

    JAMA network open 2023; (6(4)):e2310068 doi:10.1001/jamanetworkopen.2023.10068.

    PMID: 37099293
  63. 63

    Profound metabolic acidosis in association with sodium thiosulfate therapy in a patient with calcific uremic arteriolopathy: a case report and literature review.

    Abdalla M, Faris ME, Saad E, et al.

    CEN case reports 2024; (13(1)):59-65 doi:10.1007/s13730-023-00801-x.

    PMID: 37273129
  64. 64

    The application of MDT model for calciphylaxis management in patients with end-stage renal disease.

    Pan Y, Wang H, Ye Y, et al.

    International wound journal 2023; (20(9)):3717-3723 doi:10.1111/iwj.14265.

    PMID: 37309083
  65. 65

    Calciphylaxis, A Case Series: The Importance of Early Detection.

    Sijapati N, Fong SSH, Ansari O, et al.

    HCA healthcare journal of medicine 2023; (4(1)):43-49 doi:10.36518/2689-0216.1214.

    PMID: 37426565
  66. 66

    A retrospective review of outcomes after hyperbaric oxygen therapy for the treatment of calciphylaxis.

    Biglione B, Cucka B, Iriarte C, et al.

    Journal of the American Academy of Dermatology 2024; (90(1)):45-51 doi:10.1016/j.jaad.2023.07.1031.

    PMID: 37586460
  67. 67

    Multimodality approach to treat calciphylaxis in end-stage kidney disease patients.

    Lajoie C, Ghanemi A, Bourbeau K, et al.

    Renal failure 2023; (45(2)):2256413 doi:10.1080/0886022X.2023.2256413.

    PMID: 37724534
  68. 68

    Calcific Uremic Arteriolopathy in End-Stage Renal Disease: A Rare Life-Threatening Condition.

    Okan T, Ghuman K, Chaudhary F, et al.

    Cureus 2023; (15(10)):e48002 doi:10.7759/cureus.48002.

    PMID: 38034199
  69. 69

    Clinical characteristics and treatment modalities in uremic and non uremic calciphylaxis - a dermatological single-center experience.

    Yousuf S, Busch D, Renner R, et al.

    Renal failure 2024; (46(1)):2297566 doi:10.1080/0886022X.2023.2297566.

    PMID: 38178572
  70. 70

    Occlusive cutaneous vasculopathies as cause of chronic ulcers.

    Ronicke M, Berking C, Erfurt-Berge C

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2024; (22(4)):553-567 doi:10.1111/ddg.15276.

    PMID: 38379266
  71. 71

    Penile Calciphylaxis: A Successfully Treated Case.

    Misakyan N, Abu-Shanab A, Shah S

    Cureus 2024; (16(2)):e54824 doi:10.7759/cureus.54824.

    PMID: 38529436
  72. 72

    Assessment of diagnostic delay, morbidity, and mortality outcomes in 302 calciphylaxis patients over a 17-year period: A retrospective cohort study.

    Tan AJ, Xia J, Glennon CM, et al.

    Journal of the American Academy of Dermatology 2024; (91(5)):834-842 doi:10.1016/j.jaad.2024.06.058.

    PMID: 38972479
  73. 73

    Advanced Calciphylaxis in a Patient With End-Stage Renal Disease: A Case Report Highlighting Diagnostic and Therapeutic Challenges in Late-Stage Presentation.

    Chaganlal PP, Kalandoor V, Jones DT, et al.

    Cureus 2024; (16(9)):e68866 doi:10.7759/cureus.68866.

    PMID: 39246637
  74. 74

    Penile Calciphylaxis Obscured by Phimosis in an End-Stage Renal Disease Patient: A Case Report.

    Angammana CU, Fernando H, Silva F

    Cureus 2024; (16(8)):e67156 doi:10.7759/cureus.67156.

    PMID: 39295658
  75. 75

    Risk Factors Associated With the Development of Calciphylaxis in Patients With Chronic Kidney Disease: A Systematic Review.

    Ogah CO, Mohammed H, Gabra IM, et al.

    Cureus 2024; (16(12)):e75314 doi:10.7759/cureus.75314.

    PMID: 39776750
  76. 76

    Livedoid vasculopathy, calciphylaxis, and Martorell's hypertensive ulcer: update on ischemic ulcers due to impaired microcirculation of the lower limbs.

    Lacerda PN, Garcia LC, Mazeto IFDS, et al.

    Anais brasileiros de dermatologia 2025; (100(2)):215-227 doi:10.1016/j.abd.2024.09.004.

    PMID: 39848831
  77. 77

    Calciphylaxis: ongoing challenges and treatment opportunities with mesenchymal stem cells.

    Wu D, Lu S, Hu J, et al.

    Journal of molecular cell biology 2025; (17(2)) doi:10.1093/jmcb/mjaf009.

    PMID: 40097288
  78. 78

    Calciphylaxis Penile Lesion: An Unusual Complication of End-Stage Renal Disease.

    Grote J, Geyer-Roberts E, Banuelos A, et al.

    Cureus 2025; (17(3)):e80625 doi:10.7759/cureus.80625.

    PMID: 40230779
  79. 79

    Calciphylaxis of the Upper Limbs-A Rare and Serious Disease with Multidisciplinary Treatments-A Case Series and Literature Review.

    Pertea M, Benamor M, Bulgaru-Iliescu AI, et al.

    Diagnostics (Basel, Switzerland) 2025; (15(9)) doi:10.3390/diagnostics15091179.

    PMID: 40361997
  80. 80

    Calciphylaxis: A Rare Manifestation of a Common Disease.

    Nancassa C, Baiherych T, Figueiredo A

    Cureus 2025; (17(5)):e84550 doi:10.7759/cureus.84550.

    PMID: 40546520
  81. 81

    Buprenorphine for the Management of Intractable Pain in Skin Ulcers Associated With Calcific Uremic Arteriolopathy.

    Whitfield S, Pellecer DS

    Pain medicine case reports 2024; (8(6)):223-227.

    PMID: 40577429
  82. 82

    Ten tips on how to deal with calciphylaxis patients.

    Chewcharat A, Nigwekar SU

    Clinical kidney journal 2025; (18(4)):sfaf098 doi:10.1093/ckj/sfaf098.

    PMID: 40600068
  83. 83

    Elevated Perioperative Morbidity After Parathyroidectomy for Calciphylaxis Patients: A Nationwide Retrospective Observational Study.

    Bauzon J, Perez-Soto R, Jin J, et al.

    The Journal of surgical research 2025; (314()):185-190 doi:10.1016/j.jss.2025.07.011.

    PMID: 40768885
  84. 84

    A Case Report of Non-Uremic Calciphylaxis Refractory to Treatment Requiring Multidisciplinary Care.

    Lee R, Kahn H, Aiad M, Wilson M

    Case reports in dermatology 2025; (17(1)):471-477 doi:10.1159/000547832.

    PMID: 41059361
  85. 85

    Calciphylaxis diagnosis, management and future directions: a comprehensive update on behalf of the European Renal Association CKD-MBD Working Group.

    Huish S, Moore S, Alfieri C, et al.

    Clinical kidney journal 2025; (18(12)):sfaf338 doi:10.1093/ckj/sfaf338.

    PMID: 41367922
  86. 86

    Navigating Calciphylaxis in End-Stage Renal Disease: A Case Report Highlighting the Complexities of Pain Control and the Need for Greater Clinical Vigilance.

    Lau RCN, Whitwell BL, Chinawanitkit C, Ahmed F

    Cureus 2025; (17(11)):e96962 doi:10.7759/cureus.96962.

    PMID: 41409958
  87. 87

    Calciphylaxis in the Upper GI Tract in an ESRD Patient: An Atypical Presentation and Review of Literature.

    D Shirsat P, Sonavane K, Botana LR, Sachdeva B

    Case reports in nephrology 2025; (2025()):3967671 doi:10.1155/crin/3967671.

    PMID: 41472909
  88. 88

    Calciphylaxis in a patient with end-stage renal disease: Multimodality imaging and clinical correlation.

    Zaki C, Stevens KJ

    Radiology case reports 2026; (21(3)):1255-1260 doi:10.1016/j.radcr.2025.11.024.

    PMID: 41536868
  89. 89

    Lived experiences of patients with calciphylaxis (CALCI-E): a qualitative study.

    Huish S, Bingham C, Treadgold BM, Sinha S

    Journal of nephrology 2026; (39(2)):381-389 doi:10.1093/joneph/aajaf017.

    PMID: 41837776
  90. 90

    Calciphylaxis Mimicry in End-Stage Renal Disease: Acute Limb Ischemia From Calcific Peripheral Arterial Disease.

    Izadian Bidgoli A, Isayan E, Buryk Y, et al.

    Cureus 2026; (18(5)):e109854 doi:10.7759/cureus.109854.

    PMID: 42375920
  91. 91

    Calciphylaxis in chronic kidney disease: a systematic review of pathomechanisms and risk factors for calcific uremic arteriolopathy.

    Søndergaard C, Nagarajah S, Shen J, et al.

    Renal failure 2026; (48(1)):2710397 doi:10.1080/0886022X.2026.2710397.

    PMID: 42572798